Literature DB >> 21178408

The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease.

Steven Jacobson.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21178408      PMCID： PMC3080198          DOI： 10.4161/viru.1.1.10327

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  13 in total

1.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

2.  Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.

Authors:  T J Lehky; M C Levin; R Kubota; R N Bamford; A N Flerlage; S S Soldan; T P Leist; A Xavier; J D White; M Brown; T A Fleisher; L E Top; S Light; H F McFarland; T A Waldmann; S Jacobson
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells.

Authors:  J A Sakai; M Nagai; M B Brennan; C A Mora; S Jacobson
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

5.  Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation.

Authors:  Marzia Puccioni-Sohler; Leila Chimelli; Monica Merçon; Reizer R Gonçalves; Glicinia Pimenta; Celso Bianco; Maria Rios; Steven Jacobson
Journal:  J Neurol Sci       Date:  2003-03-15       Impact factor: 3.181

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

Review 7.  Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches.

Authors:  Norihiro Takenouchi; Karen Yao; Steven Jacobson
Journal:  Front Biosci       Date:  2004-09-01

8.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

9.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Authors:  C L Tendler; S J Greenberg; W A Blattner; A Manns; E Murphy; T Fleisher; B Hanchard; O Morgan; J D Burton; D L Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

10.  Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.

Authors:  Y Itoyama; S Minato; J Kira; I Goto; H Sato; K Okochi; N Yamamoto
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.